VS Code extensions deployed sandbox-evasive malware to steal system data, developer credentials, and crypto wallets.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Deprioritizes 3 Clinical Programs Following Data-Driven Review, Stock Down 8 RTTNews 05.05. Recursion Pharmaceuticals GAAP EPS of -$0.50 beats by $0.06, revenue of $14.75M misses by $3 ...